Efficacy of wIRA immediately followed by hypofractionated radiation in the treatment of locally recurrent breast cancer and other superficial tumors is documented. A prerequisite for the additive and synergistic radiosensitizing properties of hyperthermia is the assessment of resulting temperatures of tumors and normal tissues. To assess the role of hyperthermia in reversing tumor hypoxia through its effects on local blood flow, oxygen profiles in skin, subcutis, and superficial tumors have been additionally assessed during mild hyperthermia (39–43 °C).
Upon wIRA-exposure, skin surface temperatures increased from 35 to 41.6 °C within 5–12 min. Maximum temperatures of 42 °C were found in subepidermal regions, with a steady decline in deeper layers reaching 40.1 °C at a depth of 20 mm. Heating was accompanied by increases in tissue oxygen tensions. Effective hyperthermia levels (≥ 39 °C) were established in depths up to 25 mm. Following wIRA exposure, tissue temperatures returned to pretreatment levels within a few minutes, with the decay time depending on tissue depths, while pO2 values remained on therapeutical levels for 30–60 min postheat, outlasting the period needed for subsequent radiotherapy. Monitoring in the upper dermis layer of skin and recurrent breast cancers confirmed the improved O2 status during wIRA exposure and outlasted the time needed for subsequent radiotherapy.
- Superficial hyperthermia
- Skin thermography
- Skin thermometry
- Skin oxygenation
- Hyperspectral skin imaging
In radiation oncology, localized wIRA-hyperthermia (wIRA-HT) is an effective adjunct for sensitizing superficial tumors to radiation treatment . This sensitization may result from hyperthermia (HT)-induced improvements of tissue oxygenation (i.e., increase in oxygen partial pressure, pO2, “reversing hypoxia”) due to a temporary increase in local blood flow in the temperature range between 39 and 43 °C (exposure time approx. 1 h). It is noteworthy to mention that in mild hyperthermia, additional mechanisms such as (a) stimulation of anti-tumor immune responses, (b) optimization of chemotherapeutic effects (HT level: 40–43 °C), (c) inhibition of DNA repair (HT level ≥41 °C), and (d) the triggering of liposomal release of drugs (HT level: 41–42 °C; ) may also be responsible for improving therapeutic outcomes.
“Probably no area in hyperthermia research is more important than the need to accurately assess the resultant temperature of tumors or normal tissues following heating” . Although skin surface temperatures can adequately be monitored by thermography , minimally invasive temperature measurements are required to guarantee effective heating and adequate hyperthermia levels (39–43 °C) in deeper tissue layers [4, 5]. This study thus focuses on assessing temperature distribution in skin and subcutis of healthy volunteers upon localized wIRA treatment. As the tissue oxygen level is a major factor for cellular radiosensitivity , HT-induced changes in skin and subcutaneous pO2 values and oxyhemoglobin (HbO2) saturations in the microvasculature of the subpapillary tissue and the upper dermis layer are also assessed.
For further orientation, the histomorphology of the human skin and subcutis is schematically shown in Fig. 5.1.
2 Materials and Methods
2.1 Delivery of wIRA-Hyperthermia
Superficial hyperthermia was applied using the TWH 1500 wIRA-hyperthermia system (Hydrosun®, Müllheim, Germany) with two radiators, controlled independently by two thermographic cameras and safety pyrometers. Radiators were positioned 34 cm between radiator exit and skin surface, resulting in an approximate irradiance of 200 mW/cm2.
For the application of hyperthermia, the lower abdominal wall (10 treatment sessions) and the lumbar region (2 treatment sessions) of healthy volunteers (1 female, and 2 males, age: 35–49 years) were exposed to wIRA irradiation for approximately 60 min. Participation in this procedure has been found to be ethically sound by the local ethics authority, and volunteers gave their informed consent.
2.2 Noninvasive Monitoring of Skin Surface Temperatures (Thermography)
Using this therapeutic approach, maximum skin surface temperature is continuously regulated by a control circuit for each of the two radiators, which is a key element of the TWH 1500 system: When thermography assesses a hot spot and a temperature above a defined maximum (switch off temperature: 43 °C), the power supply to the respective radiator is instantly switched off via a relay. As soon as the temperature of the hot spot drops (to switch on temperature: 42.5 °C), the radiator is turned back on. In steady-state conditions, between 1 and 4 on–off cycles take place per minute. The resulting peaks in temperature traces are visible in thermography records, but also in superficial skin layers, measured invasively as described below.
A typical example of serially assessed thermographic images during the onset (0–10 min) of wIRA-HT of the skin surface and in situ positioning on the temperature probes is shown in Fig. 5.2. Respective mean region of interest (ROI) temperatures are presented in the upper right corners.
2.3 Minimally Invasive Measurement of Skin and Subcutis Temperatures (Thermometry)
Tissue temperatures within skin and subcutis of the abdominal wall were measured using fiber-optic sensors (OTG-M600, Opsens, Quebec, Canada). Characteristic and representative traces of skin surface, and intradermal and subcutaneous temperatures before, during, and after wIRA-HT are shown in Fig. 5.3.
2.4 Assessment of the Tissue Oxygenation Status
The corresponding tissue oxygen partial pressures (pO2) were assessed with the Oxylite Pro system (Oxford Optronix, Abington, UK).
Fiber-optic temperature probes (diameter: 0.7 mm) and oxygen sensors (diameter: 0.4 mm) were transepidermally inserted via 1.1 mm i.v. catheters (Vasofix™ Safety, Braun, Melsungen, Germany) down to defined tissue depths (subepidermal ≈0.5 mm, and 1–20 mm within the dermis and subcutis). For positioning of invasive catheters and probes, see Fig. 5.4.
In selected situations, hyperspectral tissue imaging (TIVITA™, Diaspective Vision, Am Salzhaff, Germany) was used to visualize the HbO2 saturation (stO2) in the microcirculation of the subpapillary/upper dermis layers  of healthy volunteers (n = 3) and in superficial chest wall tumors (two patients).
Registration of preheating and postheating temperature and oxygen levels completed the data collection upon wIRA exposure.
3 Results and Discussion
3.1 Temperature Profiles
As shown in Fig. 5.5, upon wIRA irradiation, mean temperature of the skin surface increased from a baseline of 33.4 ± 1.9 °C (mean ± SD) to 41.7 ± 0.4 °C, with the most superficial invasive probe at 1 mm recording a baseline temperature of 33.1 ± 1.7 °C, increasing to 41.8 ± 0.7 °C (10 experiments). In a tissue depth of 20 ± 1 mm, i.e., in deep subcutis, the mean temperature increased from a baseline of 34.9 ± 1.1 °C to 40.1 ± 0.6 °C (11 experiments). According to these data, wIRA irradiation results in mild hyperthermia with tissue temperatures ≥39 °C, extending to tissue depths up to 25 mm, thus confirming earlier, sporadic measurements in superficial cancers [9, 10].
Upon the start of heating, increases in tissue temperatures were steepest close to the body surface, where T > 40 °C was achieved within 4 ± 2 min, whereas up to 30 min of wIRA heating were required to reach this temperature at a depth of 20 ± 1 mm. Results in intermediate tissue layers are exemplified in Fig. 5.3.
The highly significant linear correlation between subepidermal and skin surface temperatures for a representative treatment session is shown in Fig. 5.6. There is clear evidence that the maximum tissue (i.e., subepidermal) temperatures can reach 43.5 °C, with the maximum skin surface temperature being 42.5 °C. Considering data collected in all treatment sessions, a reversing of the temperature gradient is observed, as shown in Fig. 5.7. In normothermic conditions and at hyperthermia levels ≤42 °C, no substantial gradients between mean subepidermal and skin surface temperature are found (−0.4 to 0 °C, n.s.), which means that both measuring locations yield similar temperatures. With subepidermal temperatures ≥42 °C, a temperature gradient is evident, and with subepidermal temperatures ≥43 °C, a mean temperature difference of +0.8 °C toward skin surface is observed, indicating that wIRA-HT yields the highest temperatures in the upper dermis and not at the skin surface (Figs. 5.5 and 5.6). This transepidermal gradient probably relates to increasing heat loss from the skin surface by thermal radiation and convection. Since hemoglobin is a major photochrome for wIRA, HT-induced hyperemia (associated with a higher hemoglobin content) in the subepidermal microvasculature might also contribute to this effect.
When wIRA exposure is terminated, mean temperatures of the uncovered skin surface dropped below 39 °C (i.e., below the lower level of mild HT, obligatory in the oncologic setting) within less than 2 min (Figs. 5.3 and 5.8). In tissue depths of 1–5 mm, mean temperatures dropped to the same extent (see representative examples in Fig. 5.3), whereas at depths of 10 and 20 mm, mean tissue temperature reached 39 °C within 2.5 and 4 min, respectively. These observations demonstrate that effective hyperthermia levels are only maintained for a short period in uncovered skin. This is of relevance for clinical application of superficial HT as a radiosensitizer, for which it is presumed that a simultaneous or quasi-simultaneous application of HT and subsequent radiotherapy provides the most effective synergy . In contrast to the experimental setting applied here, clinical routine aims to maintain tissue temperatures after the wIRA irradiators are switched off. When wIRA-HT is used as a radiosensitizer in the clinical setting, the patient is covered either with a prewarmed dressing gown or with a prewarmed silicone flab when being transferred from the HT unit to the linear accelerator . Therefore, the actual decline in temperature in clinical practice is expected to be significantly slower than observed in the study described herein, where the skin was left uncovered. However, additional investigations are needed to quantify the temperature decline in “heat-insulated” tissues between end of wIRA-HT and subsequent start of RT. In any case, this time interval should be kept very short (≤5 min).
3.2 Tissue Oxygenation
3.2.1 Oxyhemoglobin Saturations Assessed by Hyperspectral Imaging
Noninvasive monitoring of HbO2 saturation (stO2) in the subepidermal microvasculature also confirmed a distinct increase in tissue oxygenation upon wIRA exposure. This effect is visible both in the abdominal wall of healthy volunteers (Fig. 5.9a) and in the skin affected by locally invasive recurrent breast cancer (Fig. 5.9b). The mean HbO2 saturation (stO2) in human skin before wIRA exposure was 41%. Upon heating the skin up to 41.7 °C, the saturation almost doubled (Fig. 5.5, green triangles; Fig. 5.10, boxes and whiskers on the left). When wIRA irradiation was terminated, stO2 values decreased only slightly and thus remained distinctly elevated, even after skin temperatures dropped to baseline, as shown in Figs. 5.8 and 5.10. From these data, it is concluded that improved tissue oxygenation considerably outlasts tissue temperature rises upon wIRA-hyperthermia; i.e., oxygenation-dependent radiosensitization is expected to be fully active/maintained during RT in our clinical setting.
Hyperspectral skin imaging was found to be a versatile and noninvasive method to assess HbO2 saturations in upper skin layers. Since this method only covers the subpapillary microcirculatory vessels in the upper dermis , invasive pO2 measurements are required for oxygenation measurements in the lower dermis down to the subcutis.
3.2.2 Assessment of Tissue pO2 Values
In all tissue depths addressed (subepidermal, 8–10 mm, and 17–20 mm), wIRA-HT caused a marked, highly significant increase in the oxygenation. Mean tissue oxygen tensions in the subcutis rose from 43 to 81 mmHg at tissue depths of 8–10 mm, and from 46 to 77 mmHg at tissue depths of 17–20 mm (Figs. 5.5 and 5.10). Oxygenation reached a maximum within 25–30 min of wIRA-HT and remained at this significantly higher level in the further course of treatment. Upon cessation of wIRA irradiation, oxygenation only slowly decreased and remained at significantly elevated levels within the typical time frame of subsequent radiotherapy protocols (Figs. 5.10 and 5.11).
A similar pattern was observed by Hartel et al.  when using wIRA-hyperthermia to improve healing of surgical wounds. These authors have assessed postoperative pO2 values in a tissue depth of 20 mm. On day 2, the baseline pO2 before wIRA irradiation was 32 mmHg vs. 42 mmHg after treatment. On day 10, the respective data were 34 mmHg vs. 46 mmHg, both improvements greatly outlasting the actual time of the wIRA exposure.
As mentioned above, tissue oxygenation status before, during, and after wIRA-hyperthermia was assessed by two different approaches in our experiments:
By an indirect, noninvasive approach, using hyperspectral analysis of oxygen saturation (stO2) of hemoglobin present in subepidermal microvasculatures (Figs. 5.8 and 5.10). Although measurement in deeper tissue layers is technically not possible, this method offers the advantage of noninvasive imaging of larger skin areas (Fig. 5.9).
By direct, minimally invasive microsensor measurements of tissue oxygen pressures (p02, Figs. 5.10 and 5.11). In principle, this method may be applied at any tissue depth (Fig. 5.4).
Compared to preheating values, wIRA-HT causes a significant improvement of the tissue O2 status. Both hyperspectral imaging of stO2 and direct measurement of tissue pO2 show that this effect outlasts the period needed for subsequent RT (Figs. 5.10 and 5.11).
In Table 5.1, both baseline and steady-state pO2 values upon superficial wIRA-HT are listed together with known literature data.
4 Summary and Outlook
wIRA-HT is a reliable treatment modality for efficiently heating skin and subcutaneous tissue up to a depth of approx. 25 mm. In the set temperature range (mild hyperthermia, 39–43 °C), tissue oxygenation is substantially improved in all tissue depths examined (≈0.5–20 mm). Improvement of oxygenation considerably outlasts the wIRA heating period. In the case of superficial tumors reaching into deeper tissue layers, combination of wIRA-HT with microwave HT may broaden the application range .
- HT :
Hyperthermia (mild HT, 39–43 °C)
- i.v. :
- pO2 :
Oxygen partial pressure, O2 tension (mmHg)
- ROI :
Region of interest
- RT :
Radiotherapy, radiation treatment
- stO2 :
Oxyhemoglobin (HbO2) saturation, tissue (%)
- T :
- wIRA :
Water-filtered infrared A irradiation
Notter M, Thomsen AR, Nitsche M, et al. Combined wIRA-hyperthermia and hypofractionated re-irradiation in the treatment of locally recurrent breast cancer: evaluation of therapeutic outcome based on a novel size classification. Cancers (Basel). 2020;12:3. https://doi.org/10.3390/cancers12030606.
Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 8th ed. Philadelphia, Baltimore, New York, London, Buenos Aires: Wolters Kluwer; 2019.
Vaupel P, Piazena H, Müller W, et al. Biophysical and photobiological basics of water-filtered infrared-a hyperthermia of superficial tumors. Int J Hyperthermia. 2018;35:26–36. https://doi.org/10.1080/02656736.2018.1469169.
Dobšíček Trefná H, Crezee J, Schmidt M, et al. Quality assurance guidelines for superficial hyperthermia clinical trials : II. Technical requirements for heating devices. Strahlenther Onkol. 2017;193:351–66. https://doi.org/10.1007/s00066-017-1106-0.
Trefná HD, Crezee H, Schmidt M, et al. Quality assurance guidelines for superficial hyperthermia clinical trials: I Clinical requirements. Int J Hyperthermia. 2017;33:471–82. https://doi.org/10.1080/02656736.2016.1277791.
Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol. 2004;14:198–206. https://doi.org/10.1016/j.semradonc.2004.04.008.
Krackowizer P, Brenner E. Dicke der Epidermis und Dermis. Phlebologie. 2008;37:83–92. https://doi.org/10.1055/s-0037-1622218.
Wild T, Becker M, Winter J, et al. Hyperspectral imaging of tissue perfusion and oxygenation in wounds: assessing the impact of a micro capillary dressing. J Wound Care. 2018;27:38–51. https://doi.org/10.12968/jowc.2018.27.1.38.
Notter M, Piazena H, Vaupel P. Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients. Int J Hyperthermia. 2017;33:227–36. https://doi.org/10.1080/02656736.2016.1235731.
Seegenschmiedt MH, Klautke G, Walther E, et al. Water-filtered infrared-A-hyperthermia combined with radiotherapy in advanced and recurrent tumors. Initial results of a multicenter phase I-II study. Strahlenther Onkol. 1996;172:475–84.
Lu G, Fei B. Medical hyperspectral imaging: a review. J Biomed Opt. 2014;19:10901. https://doi.org/10.1117/1.JBO.19.1.010901.
Hartel M, Hoffmann G, Wente MN, et al. Randomized clinical trial of the influence of local water-filtered infrared A irradiation on wound healing after abdominal surgery. Br J Surg. 2006;93:952–60. https://doi.org/10.1002/bjs.5429.
Wang W, Winlove CP, Michel CC. Oxygen partial pressure in outer layers of skin of human finger nail folds. J Physiol. 2003;549:855–63. https://doi.org/10.1113/jphysiol.2002.037994.
Carreau A, El Hafny-Rahbi B, Matejuk A, et al. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med. 2011;15:1239–53. https://doi.org/10.1111/j.1582-4934.2011.01258.x.
Evans N, Naylor P. Steady states of oxygen tension in human dermis. Respir Physiol. 1966;2:46–60. https://doi.org/10.1016/0034-5687(66)90037-5.
Baumgärtl H, Ehrly AM, Saeger-Lorenz K, et al. Initial results of intracutaneous measurements of pO2 profiles. In: Ehrly AM, Hauss J, Huch R, editors. Clinical oxygen pressure measurement: Tissue oxygen pressure and transcutaneous oxygen pressure. Berlin Heidelberg: Springer; 1987. p. 121–8.
Keeley TP, Mann GE. Defining physiological normoxia for improved translation of cell physiology to animal models and humans. Physiol Rev. 2019;99:161–234. https://doi.org/10.1152/physrev.00041.2017.
Vaupel P, Mayer A, Höckel M. Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol. 2006;182:63–71. https://doi.org/10.1007/s00066-006-1543-7.
Crezee J, Zweije R, Bakker A et al. Combining 70MHz and 434MHz or wIRA hyperthermia applicators for optimal coverage of demi-deep tumour sites. In: 2019 49th European Microwave Conference: 1–3 October 2019, Paris, France. IEEE, Piscataway, pp. 164–167; 2019.
Editors and Affiliations
Rights and permissions
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
© 2022 The Author(s)
About this chapter
Cite this chapter
Thomsen, A.R., Saalmann, M.R., Nicolay, N.H., Grosu, A.L., Vaupel, P. (2022). Temperature Profiles and Oxygenation Status in Human Skin and Subcutis Upon Thermography-Controlled wIRA-Hyperthermia. In: Vaupel, P. (eds) Water-filtered Infrared A (wIRA) Irradiation. Springer, Cham. https://doi.org/10.1007/978-3-030-92880-3_5
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-92879-7
Online ISBN: 978-3-030-92880-3
eBook Packages: MedicineMedicine (R0)